PACKAGE LABEL PRINCIPAL DISPLAY PANEL

INACTIVE INGREDIENT SECTION

Cherry flavor, D&C Red #33, FD&C Red #40, glycerine, methyl paraben, propylene glycol, propyl paraben, purified water, sodium citrate, sodium saccharin

DRUG INTERACTIONS SECTION

Interaction with Potassium Sparing Diuretics: Hypokalemia should not be treated by the concomitant administration of potassium salts and potassium-sparing diuretics (e.g., spironolactone, triamterene or amiloride) since the simultaneous administration of these agents can produce severe hyperkalemia. Interaction with ACE inhibitors: Angiotensin converting enzyme (ACE) inhibitors (e.g., captopril, enlapril) will produce some potassium retention by inhibiting aldosterone production. Potassium supplements should be given to patients receiving ACE inhibitors only with close monitoring.

TOXICITY: Hyperkalemia when detected, must be treated immediately because lethal levels can be reached in a few hours. Dispense in tight, light-resistant container as defined in USP/NF. Store at 20-25 ºC (66 º to 77 ºF) Avoid Freezing.

DOSAGE AND ADMINISTRATION SECTION

To minimize gastrointestinal irritation, patients must follow direction regarding dilution. Each tablespoon (15 mL) should be diluted wtih three (3) fluid ounces or more of water or other liquid.

Usual Adult Dose: one (1) tablespoon (15 mL) twice daily (after morning or evening meals) supplies 80 mEq of Potassium.

INDICATIONS AND USAGE SECTION

For treatment of patient with hypokaleia, with or without metabolic alkalosis, in digitalis intoxication.

WARNINGS AND PRECAUTIONS SECTION

Discontinue immediatly if abdominal pain, distension, nausea, vomiting or gastrointestinal bleeeding occurs. CONTRAINDICATED in the ;presence of dehydration or impaired kidney function. Potassium iantoxication causes electrocardiographic abnormalities, flaccid paraysis of the skeletal muscles, paresthesias of the extremities, listlessness, mental confusion, weakness and heaviness of the legs, fall in blood pressure, cardiac arrhymias. Frequent checks of the clinical status of the patient, and periodic ECG and/or serum potassium levels should be made. Potassium intensifies the symptoms of myotonia congenita.